KyungDong Pharm home
Prescription Medicines

KD ATP Inj.

Product Category
ATP Energy Injection
Active Ingredients
Adenosine triphosphate disodium trihydrate
Appearance
An injection containing a colorless, transparent liquid in a colorless, transparent ampoule.
View Regulatory Information on the MFDS Portal ↗
1. Composition and Strength
- Active ingredient: Adenosine triphosphate disodium trihydrate (in-house specification) ----- 21.961mg (20mg as adenosine triphosphate disodium)
- Additives (stabilizers): Glycine (JP) ------- 20mg
- Other additives: sodium hydroxide, hydrochloric acid, water for injection

2. Efficacy/Effectiveness
Improvement of various symptoms accompanying the following diseases:
Improvement of liver function in myasthenia gravis, heart failure, chronic hepatitis, aftereffects of head trauma, and accommodative asthenopia.

3. Usage/Dosage
As disodium adenosine triphosphate, 5 to 20 mg per adult is usually injected subcutaneously, intramuscularly or intravenously 1 to 2 times a day.
For intravenous injection, mix with 10 to 20 mL of glucose injection solution and inject slowly over 3 to 5 minutes.
Increase or decrease appropriately depending on age and symptoms.

4. Precautions for use
1. Warning
Ampoule injections may contain glass fragments when cutting the container, which may cause adverse reactions. Therefore, cut carefully to minimize glass fragments when used, but be especially careful when using them in children and the elderly.

2. Do not administer to the following patients.
Patients immediately after cerebral hemorrhage (there is a possibility of rebleeding due to cerebral vasodilatation).

3. Adverse reactions
1) Shock: In rare cases, symptoms such as chest discomfort, nausea, facial flushing, coughing, hiccups, and fever may occur. If these symptoms appear, discontinue administration.
2) Circulatory system: Chest tightness, transient palpitations, arrhythmia, etc. may occur.
3) Digestive system: Nausea, vomiting, loss of appetite, stomach pain, constipation, etc. may occur.
4) Respiratory system: Coughing attacks may occur.
5) Central nervous system: Headache may occur.

4. Interaction
It has been reported that dipyridamole increases the blood concentration of adenosine, a decomposition product of this drug, and enhances its effect on the cardiovascular system, so caution should be exercised when co-administered.

5. Administration to pregnant women
Since the safety of administration during pregnancy has not been established, it is not recommended to be administered to pregnant women or women who may be pregnant.

6. Administration to children
Safety in children has not been established.

7. Administration to elderly people
In general, elderly people have reduced physiological function, so the dose should be administered with caution, such as reducing the dose.

8. Application precautions
Rapid injection into a vein may cause temporary chest discomfort, nausea, headache, facial flushing, coughing, hiccups, fever, bronchospasm, etc., so the injection speed should be as slow as possible.

5. How to save
Sealed container, stored in cool and dark place (1~15℃)

6. Packaging unit
2mL x 10Amp.

7. Period of use
24 months from date of manufacture